Mon.Jun 23, 2025

article thumbnail

Compass’ big psychedelic study doesn’t impress investors

Bio Pharma Dive

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s version of psilocybin could be as a depression treatment.

article thumbnail

Patients Don’t Want to Be Sold. They Want the Truth.

World of DTC Marketing

It’s a common misconception in pharma marketing that the goal is to “sell” a medication like you’d sell a soda or smartphone. But prescription drugs aren’t consumer goods—they are interventions in people’s health, often at critical moments in their lives. Patients aren’t looking for a sales pitch. They’re looking for trust, clarity, and reassurance that the treatment being suggested is truly proper for them.

Marketing 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Relentless innovation: Bold exploration in advancing therapeutic options for every patient, every discovery

Bio Pharma Dive

Can rethinking risk in R&D unlock breakthroughs for rare and hard-to-treat diseases?

130
130
article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

article thumbnail

The rise of GLP-1 drugs: Transforming weight loss treatment

Bio Pharma Dive

Skip to main content Dont miss tomorrows biopharma industry news Let BioPharma Dives free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy.

article thumbnail

June 23, 2025: How to Choose Patient-Reported Outcome Measures in Pragmatic Clinical Trials?

Rethinking Clinical Trials

A new section of the Living Textbook of Pragmatic Clinical Trials describes considerations for choosing patient-reported outcome measures in pragmatic clinical trials. “Where possible, investigators are encouraged to use measures with adequate support for validity that are in the public domain,” the authors wrote. The authors provide a set of questions to guide investigators in choosing approrpriate measures.

More Trending

article thumbnail

Novo abruptly ends obesity drug deal with Hims

Bio Pharma Dive

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo resolved its shortage.

Drugs 157
article thumbnail

Bridging the gap: A comprehensive approach to social determinants of health

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Illumina to buy SomaLogic in deal worth up to $425M

Bio Pharma Dive

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene sequencing products.

article thumbnail

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Marketing 130
article thumbnail

Clinical Research White Paper – Enhancing Transparency & Efficiency Throughout the Trial Lifecycle

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

article thumbnail

Cassidy calls to delay meeting of CDC’s vaccine panel in challenge to RFK Jr.

STAT News

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be delayed, citing their lack of experience and potential bias against some vaccines. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.

Vaccine 98
article thumbnail

Phase III trial shows gene therapy skin grafts help heal chronic wounds in blistering skin disease

Medical Xpress

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The grafts treat severe dystrophic epidermolysis bullosa, or EB, a genetic condition in which the skin is so fragile the slightest touch can cause blistering and wounds, eventually leading to large, open lesions that never heal and are immensely painful.

article thumbnail

STAT+: Eli Lilly drug preserves lean mass in patients losing weight on Wegovy

STAT News

CHICAGO — An investigational therapy from Eli Lilly helped preserve lean mass and drive greater loss of fat in patients taking the popular obesity treatment Wegovy. In a Phase 2 trial, patients taking the highest-dose combination of Wegovy and the drug, called bimagrumab, lost 22% of their weight at 72 weeks. Ninety-three percent of that was fat mass, and the rest was lean mass.

Drugs 81
article thumbnail

'Pill-on-a-thread' could replace endoscopies for half of all patients being monitored for esophageal cancer risk

Medical Xpress

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study by researchers at the University of Cambridge, Addenbrooke's Hospital and Queen Mary University of London. The research was published in The Lancet.

article thumbnail

Can Your Organization Spot a Conflict Before It’s a Crisis?

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

article thumbnail

STAT+: Top drug regulator is retiring as FDA departures mount

STAT News

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July.  Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.

article thumbnail

Tick risks vary by region. Here's where diseases have spread and how to stay safe

NPR Health - Shots

more than a dozen different disease-causing agents, including toxins, allergens, bacteria, parasites and viruses.'/> Tick bites are are on the rise this and they can carry some nasty illnesses. Which are most common depends where you live. Here's what to know to protect yourself.

article thumbnail

STAT+: Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing

STAT News

CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, results that support the company’s decision to use a slower dosing schedule to make the drug more tolerable in further testing.  In the Phase 2 study, patients with obesity taking the injectable drug, called MariTide, lost up to 16.2% of their weight in one year when taking into account all participants regardless of disco

Trials 81
article thumbnail

New ImmunoPET Tracer Boosts Early Liver Cancer Detection

Scienmag

A groundbreaking development in the early detection of hepatocellular carcinoma (HCC) has emerged from the halls of Wuhan Union Hospital at Huazhong University of Science and Technology. Researchers have unveiled a novel molecular imaging agent, designated 68 Ga-aGPC3-scFv or XH06, capable of precisely targeting glypican-3 (GPC3), a cell surface receptor that is prevalently overexpressed in HCC tumors.

article thumbnail

White Paper - A Roadmap to AI Data Readiness in R&D Labs

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

article thumbnail

STAT+: Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs

STAT News

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1 obesity treatments and “deceptive marketing.” Earlier this year, Novo launched a direct-to-consumer website that sells its obesity drug Wegovy at a lower price to patients who are paying on their own without insurance.

Drugs 82
article thumbnail

AI-Driven Brain Mapping Software Secures FDA Approval for Market Launch

Scienmag

A groundbreaking development in neurosurgery has emerged with the FDA’s investment in an innovative AI-based technology designed to enhance the precision of brain mapping. At the forefront of this advancement is the Cirrus Resting State fMRI Software, a remarkable tool developed by a team of researchers at Washington University School of Medicine in St.

article thumbnail

COVID-19 wastewater surveillance accurately predicts community infections

Medical Xpress

Published in The Journal of Infectious Diseases, a University of Minnesota research team has demonstrated that measuring SARS-CoV-2 in wastewater continues to accurately predict COVID-19 infections in a community.

article thumbnail

Scientists Identify Novel Genetic Target Poised to Transform Liver Cancer Therapy

Scienmag

Hepatocellular carcinoma (HCC) is one of the most formidable challenges in oncology today. Representing the predominant form of liver cancer and ranking as the third-leading cause of cancer-related mortality worldwide, HCC’s aggressive nature and resistance to conventional therapies have long stymied clinicians and researchers alike. Yet, recent groundbreaking work at the VCU Massey Comprehensive Cancer Center, led by Dr.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers

Medical Xpress

A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown to be safe and effective in human trials. Acting like a "smart missile," the dual-targeting radiopharmaceutical is designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy. Early results show that nearly 90% of patients experienced either tumor shrinkage or disease stabilization.

article thumbnail

STAT+: Compass psilocybin therapy shown to be effective in largest-ever study in depression

STAT News

Compass Pathways said Monday it achieved its primary endpoint in an early Phase 3 readout from the largest-ever study of psilocybin for treatment-resistant depression. Yet its stock price fell 36% before the markets opened, apparently signaling investor disappointment that the effect size wasn’t larger. A single dose of the psychedelic drug led to a mean reduction in a measure of clinical depression (the Montgomery-Åsberg Depression Rating Scale , or MADRS) that was 3.6 points more t

Trials 65
article thumbnail

Biocompatible Lossen Rearrangement Achieved in E. coli

Scienmag

In a groundbreaking development that could redefine the interplay between synthetic chemistry and biotechnology, researchers have unveiled a biocompatible Lossen rearrangement occurring within the cellular machinery of Escherichia coli. This unprecedented achievement, chronicled in the soon-to-be-published work by Johnson et al. in Nature Chemistry (2025), marks a decisive step towards merging classical chemical transformations with living systems.

article thumbnail

AI chatbot safeguards fail to prevent spread of health disinformation, study reveals

Medical Xpress

A study assessed the effectiveness of safeguards in foundational large language models (LLMs) to protect against malicious instruction that could turn them into tools for spreading disinformation, or the deliberate creation and dissemination of false information with the intent to harm.

69
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

LLMs Integrate Irrelevant Data When Suggesting Medical Treatments, Study Reveals

Scienmag

CAMBRIDGE, MA – Recent research from MIT has uncovered critical issues in the deployment of large language models (LLMs) in healthcare settings, particularly concerning how nonclinical details within patient communications can lead to inappropriate treatment recommendations. These findings raise concerns about the reliability and fairness of LLMs, which are increasingly tasked with evaluating patient needs and making clinical suggestions.

article thumbnail

New PET tracer delivers high-quality images of brain inflammation activity

Medical Xpress

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting and published as a supplement in the Journal of Nuclear Medicine.

article thumbnail

Climate change is boosting the risk of sleep apnea

NPR Health - Shots

Hotter temperatures make breathing problems during sleep more likely, even when it's not extremely hot (Image credit: Chris Hondros/Getty Images)

63
article thumbnail

PET imaging links brain inflammation to speech disorder and Parkinson-like syndrome

Medical Xpress

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of speech (PAOS), a rare neurodegenerative disorder that affects speech planning. These findings provide new insight into how neuroinflammation and tau pathology may drive disease progression in PAOS, opening potential avenues for earlier diagnosis and targeted treatments.

59
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model